Published in BMC Cancer on February 22, 2010
Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J (2010) 0.89
Promoter methylation of p16(INK4A), hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence. Infect Dis Obstet Gynecol (2011) 0.84
Performance evaluation of manual and automated (MagNA pure) nucleic acid isolation in HPV detection and genotyping using Roche Linear Array HPV Test. Infect Dis Obstet Gynecol (2011) 0.84
The cytology and DNA detection by the PapilloCheck(®) test in the diagnosis of human papillomavirus infection. Eur J Microbiol Immunol (Bp) (2013) 0.76
Diagnostic algorithm to reflect regressive changes of human papilloma virus in tissue biopsies. Yonsei Med J (2014) 0.75
Human papillomavirus infection by anatomical site among Greek men and women: a systematic review. Eur J Cancer Prev (2016) 0.75
Comparison of DNA testing strategies in monitoring human papillomavirus infection prevalence through simulation. BMC Infect Dis (2016) 0.75
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA (2002) 15.59
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol (1995) 10.07
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01
Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis (1994) 7.00
Chapter 1: HPV in the etiology of human cancer. Vaccine (2006) 6.61
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24
Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet (1999) 4.24
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst (2006) 4.14
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (1995) 3.59
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA (1999) 3.37
The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer (1995) 3.29
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst (2003) 3.08
Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51
HPV testing in primary screening of older women. Br J Cancer (1999) 2.44
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer (2001) 2.26
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol (1998) 2.21
Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst (2000) 1.62
Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer (1999) 1.48
Chapter 10: New dimensions in cervical cancer screening. Vaccine (2006) 1.46
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med (2003) 1.32
Detection of human papillomaviruses in cervicovaginal cells using polymerase chain reaction. J Infect Dis (1990) 1.25
Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. IARC Sci Publ (1992) 1.18
Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol (2002) 1.14
Hybrid capture-II and LCR-E7 PCR assays for HPV typing in cervical cytologic samples. Int J Cancer (2001) 1.01
Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. Diagn Mol Pathol (1999) 0.99
Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol (2000) 0.97
Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study. Int J Cancer (2006) 0.97
The evaluation and interpretation of cervical cytology: application of the likelihood ratio concept. Cytopathology (1993) 0.85
Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol (1998) 0.82
Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women. Br J Cancer (2003) 0.82
Detection of human papillomavirus in Papanicolaou smears: correlation with pathologic findings and clinical outcome. Diagn Mol Pathol (1998) 0.80
Human papillomavirus vaccine update. Curr Infect Dis Rep (2007) 0.80
Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness. Am J Obstet Gynecol (1997) 0.77
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck (2009) 2.59
E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst (2009) 2.45
The impact of endograft type on inflammatory response after endovascular treatment of abdominal aortic aneurysm. J Vasc Surg (2013) 2.07
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. Gynecol Oncol (2011) 1.60
Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52
Differential effects of stent-graft fabrics on arterial stiffness in patients undergoing endovascular aneurysm repair. J Endovasc Ther (2014) 1.46
Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol (2011) 1.27
beta-Catenin and p53 analyses of a breast carcinoma tissue microarray. Cancer (2004) 1.23
Retiform hemangioendothelioma presenting as bruise-like plaque in an adult woman. Int J Dermatol (2006) 1.22
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Hum Pathol (2011) 1.18
Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies. Arch Otolaryngol Head Neck Surg (2005) 1.16
Increasing diagnostic accuracy with a cell block preparation from thin-layer endometrial cytology: a feasibility study. Acta Cytol (2006) 1.14
Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta. Eur J Cardiothorac Surg (2004) 1.13
Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Mol Cancer Res (2010) 1.13
Treatment issues in clear cell carcinoma of the ovary: a different entity? Oncologist (2006) 1.11
Human papillomavirus-active head and neck cancer and ethnic health disparities. Laryngoscope (2010) 1.10
Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors. Clin Cancer Res (2009) 1.08
Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin Cancer Res (2005) 1.08
Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.06
Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas. BMC Cancer (2006) 1.04
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis. Clin Cancer Res (2010) 1.02
Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02
γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer. Onco Targets Ther (2012) 1.00
Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis. Otolaryngol Head Neck Surg (2009) 0.99
Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas. Cancer J (2006) 0.98
EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab. J Cancer Res Clin Oncol (2014) 0.92
Simultaneous occurrence of Warthin-like papillary carcinoma and lymphoma of the mucosa associated lymphoid tissue in Hashimoto thyroiditis. J Clin Pathol (2010) 0.92
Coexistence of differentiated thyroid carcinoma with primary thyroid lymphoma in a background of Hashimoto's thyroiditis. J Clin Oncol (2011) 0.90
Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma. Clin Cancer Res (2011) 0.90
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer. Histopathology (2010) 0.90
Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway. Ann Hematol (2010) 0.90
Dasatinib inhibits proliferation and induces apoptosis in the KASUMI-1 cell line bearing the t(8;21)(q22;q22) and the N822K c-kit mutation. Leuk Res (2012) 0.89
Nonmelanoma skin tumors involving the craniofacial region: our 22 years of experience. J Craniofac Surg (2007) 0.89
Telecytology: a tool for quality assessment and improvement in the evaluation of thyroid fine-needle aspiration specimens. Telemed J E Health (2009) 0.88
Evaluation of a multiplex real time reverse transcription PCR assay for the detection and quantitation of the most common human rotavirus genotypes. J Virol Methods (2012) 0.88
Comparison of two commercially available methods for HPV genotyping: CLART HPV2 and Linear Array HPV Genotyping tests. Anal Quant Cytopathol Histpathol (2012) 0.87
Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms. Regul Pept (2012) 0.87
The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples. Int J Gynecol Cancer (2011) 0.86
The diagnostic accuracy of two methods for E6&7 mRNA detection in women with minor cytological abnormalities. Acta Obstet Gynecol Scand (2012) 0.86
beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck. Clin Cancer Res (2005) 0.86
mRNA and DNA detection of human papillomaviruses in women of all ages attending two colposcopy clinics. PLoS One (2012) 0.85
Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector. Vaccine (2011) 0.85
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA). Cancer Sci (2008) 0.85
Vascular endothelial growth factor and endoglin expression in colorectal cancer. J Cancer Res Clin Oncol (2009) 0.84
Promoter methylation of p16(INK4A), hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence. Infect Dis Obstet Gynecol (2011) 0.84
Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution. Gynecol Oncol (2008) 0.84
Performance evaluation of manual and automated (MagNA pure) nucleic acid isolation in HPV detection and genotyping using Roche Linear Array HPV Test. Infect Dis Obstet Gynecol (2011) 0.84
Her-2 protein expression, cellular localization, and gene amplification in colorectal carcinoma. Appl Immunohistochem Mol Morphol (2007) 0.83
Study on the reproducibility of thyroid lesions telecytology diagnoses based upon digitized images. Diagn Cytopathol (2010) 0.83
Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites. Arch Otolaryngol Head Neck Surg (2009) 0.83
Genetic variability and phylogeny of high risk HPV type 16, 18, 31, 33 and 45 L1 gene in Greek women. Int J Mol Sci (2011) 0.82
Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences. Endocrine (2009) 0.82
Detection of herplex simplex virus-1 and -2 in cardiac myxomas. J Biomed Biotechnol (2012) 0.82
Effect of single dose irradiation on human glioblastoma spheroids in vitro. Oncol Rep (2004) 0.82
Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma. Laryngoscope (2012) 0.81
Post-operative Aspergillus mediastinitis in a man who was immunocompetent: a case report. J Med Case Rep (2010) 0.81
P53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek-Caucasian population. Anticancer Res (2008) 0.81
Impact of the proton pump inhibitors and CYP2C19*2 polymorphism on platelet response to clopidogrel as assessed by four platelet function assays. Thromb Res (2013) 0.81
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis. Thromb Haemost (2009) 0.81
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma. Leuk Lymphoma (2008) 0.81
Prevalence of human papillomavirus in saliva and cervix of sexually active women. Gynecol Oncol (2013) 0.80
Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma. Gynecol Oncol (2007) 0.80
The key role of bisphosphonates in the supportive care of cancer patients. Anticancer Res (2014) 0.80
Using a web-based system for the continuous distance education in cytopathology. Int J Med Inform (2009) 0.80
Clinical performance of human papillomavirus E6, E7 mRNA flow cytometric assay compared to human papillomavirus DNA typing. Anal Quant Cytol Histol (2011) 0.79
Carboplatin and paclitaxel in metastatic or recurrent cervical cancer. Int J Gynecol Cancer (2009) 0.79
Assessment of static telecytological diagnoses' reproducibility in cervical smears prepared by means of liquid-based cytology. Telemed J E Health (2012) 0.79
The role of liquid-based cytology in the investigation of breast lesions using fine-needle aspiration: a cytohistopathological evaluation. J Surg Oncol (2005) 0.79
Study on the morphology and reproducibility of the diagnosis of endometrial lesions utilizing liquid-based cytology. Cancer (2005) 0.79
Vascular tumours of the nasal septum. J Otolaryngol (2002) 0.79
Ontogeny of intrinsic innervation in the human thymus and spleen. J Histochem Cytochem (2007) 0.78
Expression of HPV-related biomarkers and grade of cervical intraepithelial lesion at treatment. Acta Obstet Gynecol Scand (2014) 0.78
Identification of women for referral to colposcopy by neural networks: a preliminary study based on LBC and molecular biomarkers. J Biomed Biotechnol (2012) 0.78
Using classification and regression trees, liquid-based cytology and nuclear morphometry for the discrimination of endometrial lesions. Diagn Cytopathol (2013) 0.78
Primary effusion lymphoma. A case report. Acta Cytol (2004) 0.78
Classification of endometrial lesions by nuclear morphometry features extracted from liquid-based cytology samples: a system based on logistic regression model. Anal Quant Cytopathol Histpathol (2014) 0.78
Use of tissue microarray to facilitate oncology research. Methods Mol Biol (2010) 0.78
Surfactant Proteins in Smoking-Related Lung Disease. Curr Top Med Chem (2016) 0.78
Potential of radial basis function neural networks in discriminating benign from malignant lesions of the lower urinary tract. Anal Quant Cytol Histol (2005) 0.78
Evaluation of topoisomerase IIa expression in pancreatic ductal adenocarcinoma: a pilot study using chromogenic in situ hybridization and immunohistochemistry on tissue microarrays. Pancreatology (2007) 0.78
Liver regeneration: immunohistochemical study of intrinsic hepatic innervation after partial hepatectomy in rats. BMC Gastroenterol (2014) 0.77
Evaluation of acute/late toxicity and local recurrence in T1-T2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT). Radiol Oncol (2013) 0.77
Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis. Anticancer Res (2007) 0.77
First line treatment for metastatic pancreatic adenocarcinoma: looking for the step forward. JOP (2014) 0.77
Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.77
Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC). Appl Immunohistochem Mol Morphol (2015) 0.77
CD20 expression in angioimmunoblastic T cell lymphoma. Leuk Lymphoma (2011) 0.77
Is there any potential clinical impact of serum phosphorus and magnesium in patients with lung cancer at first diagnosis? A multi-institutional study. Asian Pac J Cancer Prev (2015) 0.77
Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection. Am J Clin Pathol (2011) 0.77